The purpose of this study was to compare participants at-risk for trauma-related neurodegeneration with a healthy control group on outcomes associated with neurodegenerative disease, such as subjective symptoms, neurocognitive performance, plasma biomarkers, magnetic resonance imaging (MRI) volumetrics, Aβ PET, and tau PET. This evidence concerns the gene MAPT and neurodegenerative disease.